Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New therapies for alopecia areata show potential but need more research.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

More people are seeing dermatologists for hair and scalp problems now than in the past.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Non-drug therapies show promise for hair regrowth but need more research.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.